GOJO Industries, a leading global producer and marketer of skin health and hygiene solutions and the inventors of PURELL™, announces the introduction of its latest formulation, PROVON® Antimicrobial Foam Handwash with 2% Chlorhexidine Gluconate (CHG). This new formulation is one of the most effective and gentle soap formulations GOJO has launched into the healthcare market to date.
This new formulation, which exceeds the FDA Healthcare Personnel Handwash requirements, is gentle on hands making it mild enough for everyday use. This non-irritating, hypoallergenic, dermatologist-tested formulation maintains the skin’s natural moisture barrier. PROVON Antimicrobial Foam Handwash with 2% CHG also:
• Is fragrance and dye free
• Leaves hands feeling clean and soft
• Rinses quickly with no sticky, tacky residue
• Is compatible with latex gloves
“We are committed to developing safe and effective hand hygiene products,” said Jeff Hall, healthcare business vice president and general manager, GOJO. “This CHG formulation delivers strong germ kill as well as an unexpected mildness not usually associated with CHG handwashes and surgical scrubs. We know hand hygiene plays a critical role in protecting patient safety and reducing germ transmission, but practicing good hand hygiene can be difficult on your hands when you are not using the right products. This is why we continue to advance the science of hand hygiene and develop products that are efficacious and maintain skin health. This newest formulation is an example of this commitment.”
GOJO offers a full portfolio of safe and effective hand hygiene solutions including antimicrobial and non-antimicrobial soaps and PURELL® Advanced Hand Sanitizer, as well as the world’s largest portfolio of green certified soaps and hand sanitizers, which provides healthcare facilities the benefit of choosing the best hand hygiene solution to meet their needs.
Source: GOJO Industries
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
The Neglected Tropical Diseases You’ve Never Heard Of
February 27th 2024The 20 conditions, known as neglected tropical diseases (NTDs), are estimated to affect more than 1 billion people, yet many individuals have never heard of them. Heather Saunders, MPH, RN, CIC, discusses 5 of them and what is being done to prevent their spread.
The Benefits of Achieving Certifications and Training in the Field of Infection Prevention
February 20th 2024The field of health care has placed a great emphasis on infection prevention in recent years, making it imperative for professionals in this domain to obtain certifications and additional training. These credentials verify their expertise and enable them to gain access to better job prospects and higher earning potential.